United States · FDA National Drug Code directory
Fruzaqla
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63020-225_8e86a087-ef8d-424c-8cfe-208bf8d4e122
- Product NDC
- 63020-225
- Form
- CAPSULE
- Composition / generic term
- fruquintinib
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20231108
- Source listing expiry
- 20271231
Source-listed ingredients
- FRUQUINTINIB — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (63020-225-21) / 21 CAPSULE in 1 BOTTLE · 63020-225-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →